Eligard



Indications and Reactions:

Role Indications Reactions
Primary
Prostate Cancer 50.8%
Drug Use For Unknown Indication 23.0%
Hypertension 10.0%
Diabetes Mellitus 2.1%
Medical Diet 1.4%
Product Used For Unknown Indication 1.4%
Depression 1.2%
Prophylaxis 1.2%
Prostate Cancer Metastatic 1.2%
Angina Pectoris 0.9%
Precocious Puberty 0.9%
Analgesia 0.7%
Anxiety 0.7%
Breast Cancer 0.7%
Cardiac Failure 0.7%
Cardiac Failure Congestive 0.7%
Arrhythmia 0.5%
Benign Prostatic Hyperplasia 0.5%
Coronary Artery Disease 0.5%
Flushing 0.5%
Prostatic Specific Antigen Increased 17.4%
Drug Ineffective 10.7%
Pulmonary Embolism 7.4%
Injection Site Necrosis 5.8%
Product Quality Issue 5.8%
Injection Site Pain 5.0%
Myalgia 5.0%
Oedema Peripheral 5.0%
Pain 5.0%
Death 3.3%
Hot Flush 3.3%
Off Label Use 3.3%
Prostate Cancer Metastatic 3.3%
Suicidal Ideation 3.3%
Syncope 3.3%
Toxic Skin Eruption 3.3%
Blood Testosterone Increased 2.5%
Cardiac Failure 2.5%
Diabetes Mellitus 2.5%
Hemiparesis 2.5%
Secondary
Prostate Cancer 58.8%
Drug Use For Unknown Indication 8.8%
Product Used For Unknown Indication 7.7%
Hypertension 6.6%
Glaucoma 2.6%
Radical Prostatectomy 2.2%
Prophylaxis 2.0%
Supplementation Therapy 1.7%
Parkinson's Disease 1.0%
Precocious Puberty 1.0%
Premedication 1.0%
Prostate Cancer Stage I 1.0%
Anxiety 0.7%
Back Pain 0.7%
Cardiac Failure 0.7%
Erectile Dysfunction 0.7%
Essential Hypertension 0.7%
Insomnia 0.7%
Metastases To Bone 0.7%
Pain 0.7%
Prostatic Specific Antigen Increased 11.2%
Osteoporosis 9.7%
Pulmonary Embolism 9.7%
Neutropenia 8.2%
Febrile Neutropenia 7.5%
Hot Flush 5.2%
Small Intestinal Obstruction 5.2%
Drug Ineffective 4.5%
Hyperhidrosis 4.5%
Pneumonia 4.5%
Weight Increased 4.5%
Injection Site Mass 3.7%
Loss Of Consciousness 3.7%
Aspartate Aminotransferase Increased 3.0%
Hyperkalaemia 3.0%
Pathological Fracture 3.0%
Ear Discomfort 2.2%
Injection Site Scab 2.2%
Injection Site Ulcer 2.2%
Prothrombin Time Abnormal 2.2%
Concomitant
Product Used For Unknown Indication 26.1%
Prostate Cancer 19.4%
Prostate Cancer Metastatic 12.6%
Metastases To Bone 6.4%
Nausea 3.6%
Prophylaxis 3.6%
Pain 2.9%
Hormone Therapy 2.7%
Cancer Pain 2.6%
Hypertension 2.6%
Back Pain 2.3%
Vomiting 2.3%
Parkinson's Disease 2.2%
Drug Use For Unknown Indication 1.9%
Sepsis 1.8%
Bone Disorder 1.6%
Gastrooesophageal Reflux Disease 1.6%
Constipation 1.5%
Cough 1.3%
Bone Pain 1.2%
Weight Decreased 16.7%
Vomiting 11.8%
Osteonecrosis Of Jaw 11.1%
Death 7.6%
Localised Oedema 4.2%
Nausea 4.2%
Pneumonia 4.2%
Sepsis 4.2%
Tooth Extraction 4.2%
Osteonecrosis 3.5%
Pyrexia 3.5%
Transurethral Prostatectomy 3.5%
Brachial Plexus Injury 2.8%
Cerebrovascular Accident 2.8%
Dizziness 2.8%
Pigmentary Glaucoma 2.8%
Renal Failure 2.8%
Swelling 2.8%
White Blood Cell Count Decreased 2.8%
Anaemia 2.1%
Interacting
Immunosuppressant Drug Therapy 50.0%
Prostate Cancer 50.0%
Ventricular Extrasystoles 100.0%